Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001367359 | SCV001563706 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004037005 | SCV004889158 | uncertain significance | Cardiovascular phenotype | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.2552G>A (p.S851N) alteration is located in exon 21 (coding exon 21) of the JAG1 gene. This alteration results from a G to A substitution at nucleotide position 2552, causing the serine (S) at amino acid position 851 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |